Affinomer is a biotech company focused on bringing Molecularly imprinted polymer (MIP) based biosensors to the point-of-care analytical landscape.
State-of-the-art, custom-designed synthetic affinity reagents crafted to meet the specific needs of your application.
Robust
Tunable
High Affinity
Applications
Due to the versatile nature of MIPs they have the potential to be integrated as "synthetic receptors" into lateral flow devices, biosensing platforms, and IVD (In Vitro Diagnostics) processing platforms for sample preparation, purification and even enrichment. Additionally, MIPs have demonstrated huge potential in more traditional chemical separation, catalysis, and even targeted drug release.
Biosensors
Lateral flow
Assay formats
Endless potential
Our receptors have the capability of being tailored towards a large range of targets, with these being just a few examples.
and more...
Meet the team...
Joseph Lowdon, PhD
CEO & Founder
Marc Collet
CCO
Anna Schoenherr
MIP Engineer
Collaborators and funders
Affinomer B.V. Oxfordlaan 70, 6229 EV, Maastricht info@affinomer.com Copyright 2023